⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL10914260 | 0.94 | — | — | |
| SCHEMBL808507 | 0.80 | — | — | |
| SCHEMBL8677795 | 0.80 | TRPA1 (0.43) | — | |
| SCHEMBL1166877 | 0.78 | — | — | |
| SCHEMBL10001 | 0.76 | — | — | |
| SCHEMBL28060459 | 0.76 | ALDH1A1 (1.00) | — | |
| SCHEMBL5615302 | 0.76 | — | — | |
| SCHEMBL6715177 | 0.76 | PAOX (0.56) | — | |
| SCHEMBL11256600 | 0.76 | PAOX (0.56) | — | |
| Ethylene SCHEMBL10374939 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111747837-A | Synthesis method of trans-4-oxo-2-hexenal | 苏州华道生物药业股份有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-110295025-A | A kind of antibacterial aqueous polyurethane adhesive and preparation method thereof | 福建华夏蓝新材料科技有限公司 | 2019-10-01 | — | — | CN | claimed |
| CN-110003159-A | Synthesize the new method of catechin | 斯法尔制药私人有限公司 | 2019-07-12 | — | — | CN | claimed |
| CN-106639977-B | A kind of selective water plugging method of oil well in oil recovery process | 张会利 | 2019-04-02 | — | — | CN | claimed |
| CN-106639977-A | Selective water plugging method of oil well in oil extraction process | 张会利 | 2017-05-10 | — | — | CN | claimed |
| EP-2948437-A2 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | Sphaera Pharma Pvt. Ltd. (IN) | 2015-12-02 | — | — | EP | claimed |
| CN-105026384-A | Novel method for synthesizing catechin | SPHAERA PHARMA PRIVATE LTD | 2015-11-04 | — | — | CN | claimed |
| CN-104478685-A | Method for preparing bromine butanone | SUZHOU JONATHAN NEW MATERIALS TECHNOLOGY CO LTD | 2015-04-01 | — | — | CN | claimed |
| WO-2014115174-A2 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | SPHAERA PHARMA PVT. LTD. (IN) | 2014-07-31 | — | — | WO | claimed |
| CN-102875543-B | 4-tertiary butyl-5-(1, 2, 4-triazole-1-base)-2-aminothiazole preparation method | UNIV HUNAN | 2014-07-02 | — | — | CN | claimed |
| CN-103582635-A | A novel process for synthesis of polyphenols | SPHAERA PHARMA PRIVATE LTD | 2014-02-12 | — | — | CN | claimed |
| CN-103449992-A | Bromo-butanone synthesis method | TIANJIN QUANHECHENG TECHNOLOGY CO LTD | 2013-12-18 | — | — | CN | claimed |
| CN-103333168-A | Amide compound, and preparation method and application thereof | UNIV TSINGHUA | 2013-10-02 | — | — | CN | claimed |
| EP-1007530-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 2000-06-14 | — | — | EP | claimed |
| EP-0929563-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | Abbott Laboratories (US) | 1999-07-21 | — | — | EP | claimed |
| EP-0918783-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1998009978-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | ABBOTT LABORATORIES (US) | 1998-03-12 | — | — | WO | claimed |
| WO-1997042204-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| CN-122010969-A | Aminated 20 (S) -10, 11-difluoro methylenedioxy camptothecin derivative, and preparation method and application thereof | 浙江工业大学 | 2026-05-12 | — | — | CN | disclosed |
| US-12479784-B2 | Trisphenol derivative | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20250070166-A1 | CATHODE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Jinko Energy Storage Co., Ltd. (CN) | 2025-02-27 | — | — | US | disclosed |
| CN-118867212-B | Positive electrode material, preparation method and application thereof | 浙江晶科储能有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-118867212-A | Positive electrode material, preparation method and application thereof | 浙江晶科储能有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-11827743-B2 | Polymers having stable cationic pendant groups for use as anion exchange membranes | UNIVERSITY OF DELAWARE (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230241243-A1 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | ELUCIDA ONCOLOGY, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230234905-A1 | NOVEL TRISPHENOL DERIVATIVE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20230159560-A1 | METHODS OF USING HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS | APTUIT (VERONA) SRL, AN EVOTEC COMPANY (IT) | 2023-05-25 | — | — | US | disclosed |
| US-11648253-B2 | Thienopyrimidinone NMDA receptor modulators and uses thereof | NOVARTIS AG (CH) | 2023-05-16 | — | — | US | disclosed |
| CN-115916734-A | Novel triphenol derivatives | 本州化学工业株式会社 | 2023-04-04 | — | — | CN | disclosed |
| EP-4100008-A1 | PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS | The Rockefeller University (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-3983073-A1 | SUBSTITUTED PYRAZOLO[4,3-B]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | disclosed |
| US-20220089592-A1 | IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS | BIOGEN MA INC. | 2022-03-24 | — | — | US | disclosed |
| WO-2022004506-A1 | NOVEL TRISPHENOL DERIVATIVE | 本州化学工業株式会社 | 2022-01-06 | — | — | WO | disclosed |
| EP-3911652-A1 | IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS | Biogen MA Inc. (US) | 2021-11-24 | — | — | EP | disclosed |
| WO-2021158936-A1 | PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS | THE ROCKEFELLER UNIVERSITY (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2020249791-A1 | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020240199-A1 | THERAPEUTIC COMPOUNDS | THE UNIVERSITY OF NOTTINGHAM (GB) | 2020-12-03 | — | — | WO | disclosed |
| CN-111747837-A | Synthesis method of trans-4-oxo-2-hexenal | 苏州华道生物药业股份有限公司 | 2020-10-09 | — | — | CN | disclosed |
| WO-2020150626-A1 | IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS | BIOGEN MA INC. (US) | 2020-07-23 | — | — | WO | disclosed |
| CN-111433206-A | Compound (I) | 葛兰素史克知识产权开发有限公司 | 2020-07-17 | — | — | CN | disclosed |
| EP-3679043-A1 | VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO | Blackthorn Therapeutics, Inc. (US) | 2020-07-15 | — | — | EP | disclosed |
| EP-3644992-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | Merck Sharp & Dohme Corp. (US) | 2020-05-06 | — | — | EP | disclosed |
| WO-2019244066-A2 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2019-12-26 | — | — | WO | disclosed |
| CN-110295025-A | A kind of antibacterial aqueous polyurethane adhesive and preparation method thereof | 福建华夏蓝新材料科技有限公司 | 2019-10-01 | — | — | CN | disclosed |
| EP-3538088-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | 3-V Biosciences, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| CN-110218218-A | Benzofuran derivative, preparation method and its application in medicine | 江苏恒瑞医药股份有限公司 | 2019-09-10 | — | — | CN | disclosed |
| EP-3532476-A1 | FUSED AZAHETEROCYCLIC COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2019-09-04 | — | — | EP | disclosed |
| CN-104936958-B | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators | 詹森药业有限公司 | 2019-07-26 | — | — | CN | disclosed |
| CN-110062761-A | Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and their use as GLUN2B receptor modulators | 詹森药业有限公司 | 2019-07-26 | — | — | CN | disclosed |
| CN-110003159-A | Synthesize the new method of catechin | 斯法尔制药私人有限公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-109988095-A | A kind of preparation method of the double contracting thiosemicarbazides of 3- phthalimide -2- oxygen-n-butanal | 淮北师范大学 | 2019-07-09 | — | — | CN | disclosed |
| CN-109928967-A | A kind of cyclisation berberinc derivate and its preparation method and application | 中国医学科学院医药生物技术研究所 | 2019-06-25 | — | — | CN | disclosed |
| CN-109925312-A | For treating the composition, preparation and method of eye disease | 爱尔皮奥治疗有限公司 | 2019-06-25 | — | — | CN | disclosed |
| EP-3484878-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | Bristol-Myers Squibb Company (US) | 2019-05-22 | — | — | EP | disclosed |
| CN-109771421-A | The method for treating vascular leak syndrome | 爱尔皮奥治疗有限公司 | 2019-05-21 | — | — | CN | disclosed |
| CN-105473558-B | Aromatic yl sulfide derivative and aryl oxysulfide derivative as acaricide and insecticide | 拜耳作物科学股份公司 | 2019-04-19 | — | — | CN | disclosed |
| CN-105307498-B | Compositions, formulations and methods for treating ocular diseases | 爱尔皮奥治疗有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109574988-A | A kind of compound and application thereof | 成都海博锐药业有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-109575022-A | A kind of compound and application thereof | 成都海博锐药业有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-106639977-B | A kind of selective water plugging method of oil well in oil recovery process | 张会利 | 2019-04-02 | — | — | CN | disclosed |
| EP-3455212-A1 | INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR-2 | Heptares Therapeutics Limited (GB) | 2019-03-20 | — | — | EP | disclosed |
| WO-2019050988-A1 | VASOPRESSIN RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO | BLACKTHORN THERAPEUTICS, INC. (US) | 2019-03-14 | — | — | WO | disclosed |
| CN-103582635-B | Method for synthesizing polyphenol | 斯法尔制药私人有限公司 | 2019-02-19 | — | — | CN | disclosed |
| US-10202400-B2 | Cortistatin analogues and syntheses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-02-12 | — | — | US | disclosed |
| WO-2019005587-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME CORP. (US) | 2019-01-03 | — | — | WO | disclosed |
| CN-108658816-A | Trifluoroethyl sulfide derivatives as the substitution of the N- aryl amidines of acaricide and insecticide | 拜尔农作物科学股份公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-108635350-A | The method for treating vascular leak syndrome | 爱尔皮奥治疗有限公司 | 2018-10-12 | — | — | CN | disclosed |
| US-20180221279-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | UNIV BRITISH COLUMBIA (CA) | 2018-08-09 | — | — | US | disclosed |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2018-07-19 | — | — | US | disclosed |
| CN-108276358-A | Trifluoroethyl sulfide derivatives as the substitution of the N- aryl amidines of acaricide and insecticide | 拜尔农作物科学股份公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-108232297-A | Electrolyte solution and secondary battery | 宁德时代新能源科技股份有限公司 | 2018-06-29 | — | — | CN | disclosed |
| CN-108101948-A | Macrocyclic compound and its making and use method | 瑞伯-X医药品有限公司 | 2018-06-01 | — | — | CN | disclosed |
| CN-104817486-B | A kind of synthetic method of ramipril intermediate | 浙江工业大学 | 2018-05-22 | — | — | CN | disclosed |
| CN-108047086-A | Composition containing alpha-non-natural amino acid and polypeptide, be related to the method for alpha-non-natural amino acid and polypeptide with and application thereof | AMBRX公司 | 2018-05-18 | — | — | CN | disclosed |
| WO-2018089904-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | 3-V BIOSCIENCES, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| US-9968554-B2 | Modified drugs for use in liposomal nanoparticles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-05-15 | — | — | US | disclosed |
| CN-105189484-B | Cxcr7 antagonists | 凯莫森特里克斯股份有限公司 | 2018-05-04 | — | — | CN | disclosed |
| WO-2018080916-A1 | FUSED AZAHETEROCYCLIC COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-03 | — | — | WO | disclosed |
| CN-104768554-B | Triazol compound | 霍夫曼-拉罗奇有限公司 | 2018-04-17 | — | — | CN | disclosed |
| CN-107892689-A | One kind cyclisation berberinc derivate and its production and use | 中国医学科学院医药生物技术研究所 | 2018-04-10 | — | — | CN | disclosed |
| US-9931407-B2 | Silicon based drug conjugates and methods of using same | BLINKBIO, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| CN-107674013-A | Polycyclic compound, its preparation method, pharmaceutical composition and application | 上海迪诺医药科技有限公司 | 2018-02-09 | — | — | CN | disclosed |
| WO-2018013774-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-01-18 | — | — | WO | disclosed |
| CN-107573351-A | A kind of method for synthesizing nitrogen-containing heterocycle compound | 淮南师范学院 | 2018-01-12 | — | — | CN | disclosed |
| CN-105503850-B | N [base of 4 tert-butyl group 5 (base of 1,2,4 triazole 1) thiazole 2] lauramides and its application | 湖南大学 | 2018-01-09 | — | — | CN | disclosed |
| CN-107548396-A | Kv1.3 inhibitors and medical uses thereof | 4SC股份公司 | 2018-01-05 | — | — | CN | disclosed |
| CN-107548397-A | Kv1.3 inhibitors and medical uses thereof | 4SC股份公司 | 2018-01-05 | — | — | CN | disclosed |
| WO-2017205964-A1 | AMINOSTEROID DERIVATIVES AND PROCESS FOR PRODUCING SAME | UNIVERSITé LAVAL (CA) | 2017-12-07 | — | — | WO | disclosed |
| WO-2017194716-A1 | INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR-2 | ASTRAZENECA AB (SE) | 2017-11-16 | — | — | WO | disclosed |
| US-20170320886-A1 | CORTISTATIN ANALOGUES AND SYNTHESES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-11-09 | — | — | US | disclosed |
| CN-107207467-A | 2, 4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG | 癌症研究科技有限公司 | 2017-09-26 | — | — | CN | disclosed |
| EP-3215505-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | Bayer Pharma Aktiengesellschaft (DE) | 2017-09-13 | — | — | EP | disclosed |
| CN-107108591-A | It is used as the resorcinol analog derivative of HSP90 inhibitor | 正大天晴药业集团股份有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-104918938-B | The novel derovatives of three ring 3,4 dihydro 2H pyridos [1,2 a] pyrazine 1,6 as gamma secretase modulators | 詹森药业有限公司 | 2017-08-15 | — | — | CN | disclosed |
| EP-2024349-B1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | ABBVIE INC (US) | 2017-08-02 | — | — | EP | disclosed |
| CN-107001350-A | Effective and expansible synthesis of the carboxylate methyl ester of 2 (carbonyl of 1 ' H indoles 3 ') thiazole 4 and its analogue | AHR制药股份公司 | 2017-08-01 | — | — | CN | disclosed |
| US-9714255-B2 | Cortistatin analogues and syntheses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-07-25 | — | — | US | disclosed |
| US-9714270-B2 | a4B7 integrin thioether peptide antagonists | PROTAGONIST THERAPEUTICS, INC. (US) | 2017-07-25 | — | — | US | disclosed |
| US-20170202970-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO, INC. | 2017-07-20 | — | — | US | disclosed |
| CN-106639977-A | Selective water plugging method of oil well in oil extraction process | 张会利 | 2017-05-10 | — | — | CN | disclosed |
| US-20170121344-A1 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | SIGA TECHNOLOGIES, INC. (US) | 2017-05-04 | — | — | US | disclosed |
| CN-106562962-A | Composition and method for treating ocular edema, neovascularization and related disease | 爱尔皮奥治疗有限公司 | 2017-04-19 | — | — | CN | disclosed |
| CN-104774199-B | 2‑（2 benzyl hydrazono-s）‑5‑（1,2,4 triazole, 1 base）Thiazole and its preparation and application | 湖南大学 | 2017-03-08 | — | — | CN | disclosed |
| CN-103249718-B | 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres | 莱雅公司 | 2017-01-18 | — | — | CN | disclosed |
| CN-104557666-B | Method of synthesizing 3-phthalimide-2-oxobutryaldehyde-1, 2-bis-thiosemicarbazide | 烟台贝森医药科技有限公司 | 2017-01-18 | — | — | CN | disclosed |
| EP-3107910-A1 | NEW PHENYLAZETIDINE, CARBOXYLATE OR CARBOXAMIDE COMPOUNDS | INVENTIVA (FR) | 2016-12-28 | — | — | EP | disclosed |
| WO-2016201168-A1 | OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF | FORUM PHARMCEUTICALS INC. (US) | 2016-12-15 | — | — | WO | disclosed |
| US-9518000-B2 | Bicyclo [2.2.1] acid GPR120 modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-12-13 | — | — | US | disclosed |
| CN-104583208-B | Can be used for treating substituted 3,4-dihydro-2H-pyrido [1,2-a] pyrazine-1,6-derovatives of (especially) Alzheimer | 杨森制药公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105793265-A | Imidazole derivative used as antiviral agent and use thereof in preparation of medicament | 南京明德新药研发股份有限公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-103797000-B | Amidine compound or salt thereof | 大正制药株式会社 | 2016-07-06 | — | — | CN | disclosed |
| EP-3036220-A1 | ANTIVIRAL COMPOUNDS | Alios Biopharma, Inc. (US) | 2016-06-29 | — | — | EP | disclosed |
| CN-103420977-B | There is the acetylene-derivative of anti-tumor activity | 上海医药集团股份有限公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105636936-A | Antiviral compounds | ALIOS BIOPHARMA INC | 2016-06-01 | — | — | CN | disclosed |
| WO-2016071216-A1 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-05-12 | — | — | WO | disclosed |
| CN-101854930-B | Novel STAT3 pathway inhibitor and cancer stem cell pathway inhibitor | Beijing Qiangxin Biotechnology Co.,Ltd. (CN) | 2016-05-04 | — | — | CN | disclosed |
| EP-3008042-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | Orion Corporation (FI) | 2016-04-20 | — | — | EP | disclosed |
| CN-105503850-A | N-[5-(1,2,4-triazol-1-yl)thiazol-2-yl]lauramide and application thereof | UNIV HUNAN | 2016-04-20 | — | — | CN | disclosed |
| CN-105473558-A | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides | BAYER CROPSCIENCE AG | 2016-04-06 | — | — | CN | disclosed |
| CN-105412094-A | Compounds, Compositions, And Methods For Preventing Metastasis Of Cancer Cells | AKEBIA THERAPEUTICS INC | 2016-03-23 | — | — | CN | disclosed |
| US-20160031944-A1 | a4B7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS | PROTAGONIST THERAPEUTICS, INC. | 2016-02-04 | — | — | US | disclosed |
| CN-105307498-A | Compositions, formulations and methods for treating ocular diseases | AERPIO THERAPEUTICS INC | 2016-02-03 | — | — | CN | disclosed |
| CN-105272953-A | Method for synthesizing coumarone naphthoquinone derivative | UNIV CENTRAL SOUTH | 2016-01-27 | — | — | CN | disclosed |
| US-20160016880-A1 | BICYCLO [2.2.1] ACID GPR120 MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2016-01-21 | — | — | US | disclosed |
| EP-2967066-A1 | COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES | Aerpio Therapeutics Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-103096718-B | Soluble guanylate cyclase activators | MERCK SHARP & DOHME CORP. (US) | 2016-01-20 | — | — | CN | disclosed |
| CN-102014626-B | Non-steroidal ligand and the application in gene switching regulation and control thereof | INTREXON CORP. (US) | 2016-01-13 | — | — | CN | disclosed |
| US-20150376201-A1 | CORTISTATIN ANALOGUES AND SYNTHESES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-12-31 | — | — | US | disclosed |
| CN-105189484-A | Cxcr7 antagonists | CHEMOCENTRYX INC | 2015-12-23 | — | — | CN | disclosed |
| EP-2953949-A1 | NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS | Janssen Pharmaceutica NV (BE) | 2015-12-16 | — | — | EP | disclosed |
| CN-102271682-B | Be used for the treatment of the P2X of pain 3receptor antagonist | MERCK SHARP & DOHME CORP. (US) | 2015-12-16 | — | — | CN | disclosed |
| CN-102596954-B | JAK2 inhibitor and be used for the treatment of the purposes of myeloproliferative disease and cancer | BRISTOL-MYERS SQUIBB CO. (US) | 2015-12-16 | — | — | CN | disclosed |
| CN-101273027-B | The macrocyclic hcv inhibitors of hepatitis C virus | JANSSEN R&D IRELAND (IE) | 2015-12-02 | — | — | CN | disclosed |
| EP-2945944-A1 | NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2015-11-25 | — | — | EP | disclosed |
| WO-2015175845-A1 | BENZIMIDAZOLE DERIVATIVES AND USES THEREOF | PELOTON THERAPEUTICS, INC. (US) | 2015-11-19 | — | — | WO | disclosed |
| CN-105026384-A | Novel method for synthesizing catechin | SPHAERA PHARMA PRIVATE LTD | 2015-11-04 | — | — | CN | disclosed |
| US-9156818-B2 | Hepatitis C virus inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| CN-103664928-B | N- [5- (1,2, 4-triazol-1-yl) thiazol-2-yl ] fatty amide and application thereof | HUNAN UNIVERSITY (CN) | 2015-10-07 | — | — | CN | disclosed |
| CN-104936958-A | Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators | JANSSEN PHARMACEUTICA NV | 2015-09-23 | — | — | CN | disclosed |
| CN-104918938-A | Novel tricyclic 3,4-dihydro-2h-pyrido[1,2-[alpha]]pyrazine-1,6-dione derivatives as gamma secretase modulators | JANSSEN PHARMACEUTICA NV | 2015-09-16 | — | — | CN | disclosed |
| US-9127019-B2 | Cortistatin analogues and synthesis thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-09-08 | — | — | US | disclosed |
| WO-2015124868-A1 | NEW PHENYLAZETIDINE, CARBOXYLATE OR CARBOXAMIDE COMPOUNDS | INVENTIVA (FR) | 2015-08-27 | — | — | WO | disclosed |
| CN-104817486-A | Ramipril intermediate synthesis method | UNIV ZHEJIANG TECHNOLOGY | 2015-08-05 | — | — | CN | disclosed |
| CN-103333168-B | A kind of amides and preparation method thereof and application | TSINGHUA UNIVERSITY (CN) | 2015-08-05 | — | — | CN | disclosed |
| CN-104803865-A | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | AMBRX INC | 2015-07-29 | — | — | CN | disclosed |
| CN-104774199-A | 2-(2-benzylidene hydrazino)-5-(1,2,4-triazole-1-yl)thiazole, and preparation and applications thereof | UNIV HUNAN | 2015-07-15 | — | — | CN | disclosed |
| CN-104768554-A | Triazolo compounds | HOFFMANN LA ROCHE | 2015-07-08 | — | — | CN | disclosed |
| CN-103664927-B | N-[5-(1,2,4-triazole-1-yl)thiazole-2-yl]aryl amide, preparation method, and applications thereof | UNIV HUNAN | 2015-06-24 | — | — | CN | disclosed |
| CN-102239167-B | Imidazopyridine derivatives for inhibiting gastric acid secretion | MIKAEL DAHLSTROEM | 2015-06-17 | — | — | CN | disclosed |
| EP-2877472-A1 | NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITION AND METHODS THEREOF | Hutchison Medipharma Limited (CN) | 2015-06-03 | — | — | EP | disclosed |
| CN-104628716-A | N-[5-(1,2,4-triazolyl-1-yl)thiazolyl-2-yl]lauramide and application thereof | UNIV HUNAN | 2015-05-20 | — | — | CN | disclosed |
| EP-2181704-B1 | Drug delivery from rapid gelling polymer composition | ANGIOTECH INT AG (CH) | 2015-05-06 | — | — | EP | disclosed |
| CN-104592351-A | ANTIPROLIFERATIVE COMPOUNDS, CONJUGATES THEREOF, METHODS THEREFOR, AND USES THEREOF | MEDAREX INC | 2015-05-06 | — | — | CN | disclosed |
| CN-104583208-A | Substituted 3, 4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives useful for the treatment of (inter alia) alzheimer's disease | JANSSEN PHARMACEUTICALS INC | 2015-04-29 | — | — | CN | disclosed |
| CN-104557666-A | Novel method of synthesizing 3-phthalimide-2-oxobutryaldehyde-1, 2-bis-thiosemicarbazide | YANTAI BESTENPHARM TECHNOLOGY CO LTD | 2015-04-29 | — | — | CN | disclosed |
| CN-104583218-A | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation | BRISTOL MYERS SQUIBB CO | 2015-04-29 | — | — | CN | disclosed |
| US-20150111921-A1 | CORTISTATIN ANALOGUES AND SYNTHESES THEROF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-04-23 | — | — | US | disclosed |
| CN-104478685-A | Method for preparing bromine butanone | SUZHOU JONATHAN NEW MATERIALS TECHNOLOGY CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-104478685-A | Method for preparing bromine butanone | SUZHOU JONATHAN NEW MATERIALS TECHNOLOGY CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-104478685-A | Method for preparing bromine butanone | SUZHOU JONATHAN NEW MATERIALS TECHNOLOGY CO LTD | 2015-04-01 | — | — | CN | disclosed |
| EP-2850083-A1 | SUBSTITUTED 3, 4 - DIHYDRO - 2H - PYRIDO [1, 2 -A]PYRAZINE - 1, 6 - DIONE DERIVATIVES USEFUL FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE | Janssen Pharmaceuticals, Inc. (US) | 2015-03-25 | — | — | EP | disclosed |
| WO-2015026792-A1 | ANTIVIRAL COMPOUNDS | ALIOS BIOPHARMA, INC. (US) | 2015-02-26 | — | — | WO | disclosed |
| CN-102725001-B | Antiproliferative compounds, conjugates thereof, methods thereof, and uses thereof | MEDAREX INC | 2015-01-14 | — | — | CN | disclosed |
| WO-2014202827-A1 | NOVEL CYP17 INHIBITORS/ANTIANDROGENS | ORION CORPORATION (FI) | 2014-12-24 | — | — | WO | disclosed |
| CN-104244715-A | Pesticidal compositions and methods related thereto | DOW AGROSCIENCES LLC | 2014-12-24 | — | — | CN | disclosed |
| US-20140356417-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2014-12-04 | — | — | US | disclosed |
| CN-104125773-A | N-arylamidine substituted trifluoroethyl sulfide derivatives as acaricides and insecticides | BAYER CROPSCIENCE AG | 2014-10-29 | — | — | CN | disclosed |
| WO-2014144210-A2 | COMPETITIVE GROWTH AND/OR PRODUCTION ADVANTAGE FOR BUTANOLOGEN MICROORGANISM | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014145068-A1 | COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES | AERPIO THERAPEUTICS INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| CN-103976998-A | Compounds, compositions, and methods for preventing metastasis of cancer cells | AERPIO THERAPEUTICS INC | 2014-08-13 | — | — | CN | disclosed |
| US-8790691-B2 | Modified drugs for use in liposomal nanoparticles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2014-07-29 | — | — | US | disclosed |
| WO-2014111457-A1 | NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2014-07-24 | — | — | WO | disclosed |
| CN-102875543-B | 4-tertiary butyl-5-(1, 2, 4-triazole-1-base)-2-aminothiazole preparation method | UNIV HUNAN | 2014-07-02 | — | — | CN | disclosed |
| WO-2014096212-A1 | NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2014-06-26 | — | — | WO | disclosed |
| CN-103874697-A | Dibenzooxepin derivative | KYOWA HAKKO KIRIN CO LTD | 2014-06-18 | — | — | CN | disclosed |
| CN-103797000-A | Amidine compound or salt thereof | TAISHO PHARMACEUTICAL CO LTD | 2014-05-14 | — | — | CN | disclosed |
| US-8703784-B2 | Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin | MERCK SHARP & DOHME CORP. (US) | 2014-04-22 | — | — | US | disclosed |
| CN-103732061-A | Carbonyl containing compounds for controlling and repelling cimicidae populations | SEMIOSBIO TECHNOLOGIES INC | 2014-04-16 | — | — | CN | disclosed |
| CN-103664927-A | N-[5-(1,2,4-triazole-1-yl)thiazole-2-yl]aryl amide, preparation method, and applications thereof | UNIV HUNAN | 2014-03-26 | — | — | CN | disclosed |
| CN-103664928-A | N- [5- (1,2, 4-triazol-1-yl) thiazol-2-yl ] fatty amide and application thereof | UNIV HUNAN | 2014-03-26 | — | — | CN | disclosed |
| CN-102603825-B | 5-thioxylopyranose derivatives | FOURNIER LAB SA | 2014-03-12 | — | — | CN | disclosed |
| EP-2694482-A1 | WNT PATHWAY ANTAGONISTS | Siena Biotech S.p.A. (IT) | 2014-02-12 | — | — | EP | disclosed |
| CN-103582635-A | A novel process for synthesis of polyphenols | SPHAERA PHARMA PRIVATE LTD | 2014-02-12 | — | — | CN | disclosed |
| US-20140039200-A1 | ORGANOGOLD COMPLEXES AND METHODS FOR MAKING THE SAME | THE UNIVERSITY OF SUSSEX (GB) | 2014-02-06 | — | — | US | disclosed |
| WO-2014015830-A1 | NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITION AND METHODS THEREOF | HUTCHISON MEDIPHARMA LIMITED (CN) | 2014-01-30 | — | — | WO | disclosed |
| WO-2014015523-A1 | NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS | HUTCHISON MEDIPHARMA LIMITED (CN) | 2014-01-30 | — | — | WO | disclosed |
| WO-2014015675-A1 | NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS | HUTCHISON MEDIPHARMA LIMITED (CN) | 2014-01-30 | — | — | WO | disclosed |
| CN-103547249-A | Dye composition comprising at least four dye precursors including at least one oxidation base and at least one coupler | OREAL | 2014-01-29 | — | — | CN | disclosed |
| EP-2681194-A1 | 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2014-01-08 | — | — | EP | disclosed |
| CN-103449992-A | Bromo-butanone synthesis method | TIANJIN QUANHECHENG TECHNOLOGY CO LTD | 2013-12-18 | — | — | CN | disclosed |
| EP-2668176-A2 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | Sphaera Pharma Pte. Ltd (SG) | 2013-12-04 | — | — | EP | disclosed |
| CN-101925603-B | Modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMA | 2013-12-04 | — | — | CN | disclosed |
| CN-103420977-A | Acetylene derivative with anti-tumor activity | SHANGHAI PHARMACEUTICAL GROUP CO LTD | 2013-12-04 | — | — | CN | disclosed |
| CN-103421005-A | Acetylene derivative capable of resisting activity of tumor | SHANGHAI PHARMACEUTICAL GROUP CO LTD | 2013-12-04 | — | — | CN | disclosed |
| EP-2665727-A1 | BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES | Abbvie Inc. (US) | 2013-11-27 | — | — | EP | disclosed |
| WO-2013171712-A1 | SUBSTITUTED 3, 4 - DIHYDRO - 2H - PYRIDO [1, 2 -A] PYRAZINE - 1, 6 - DIONE DERIVATIVES USEFUL FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE | Janssen Pharmaceuticals, Inc. (US) | 2013-11-21 | — | — | WO | disclosed |
| US-8568772-B2 | Modified drugs for use in liposomal nanoparticles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-10-29 | — | — | US | disclosed |
| EP-2651915-A1 | CONTINUOUS ARYCYCLIC COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2013-10-23 | — | — | EP | disclosed |
| CN-103347565-A | Compositions and methods for treating ocular edema, neovascularization, and related diseases | AKEBIA THERAPEUTICS INC | 2013-10-09 | — | — | CN | disclosed |
| CN-103333168-A | Amide compound, and preparation method and application thereof | UNIV TSINGHUA | 2013-10-02 | — | — | CN | disclosed |
| US-8545876-B1 | Modified drugs for use in liposomal nanoparticles | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-10-01 | — | — | US | disclosed |
| US-8545877-B2 | Modified drugs for use in liposomal nanoparticles | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-10-01 | — | — | US | disclosed |
| US-20130236534-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | UNIV BRITISH COLUMBIA (CA) | 2013-09-12 | — | — | US | disclosed |
| US-20130230583-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | UNIV BRITISH COLUMBIA (CA) | 2013-09-05 | — | — | US | disclosed |
| US-20130230582-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | UNIV BRITISH COLUMBIA (CA) | 2013-09-05 | — | — | US | disclosed |
| EP-2624916-A2 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | Aerpio Therapeutics Inc. (US) | 2013-08-14 | — | — | EP | disclosed |
| CN-103221403-A | Heterocyclic compounds and their use | AMGEN INC | 2013-07-24 | — | — | CN | disclosed |
| US-20130150353-A1 | Fused Tricyclic Inhibitors of Mammalian Target of Rapamycin | MERCK SHARP & DOHME LLC | 2013-06-13 | — | — | US | disclosed |
| US-20130129677-A1 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections | SIGA TECHNOLOGIES, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2588467-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY | Amgen Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| CN-103096718-A | Soluble guanylate cyclase activators | MERCK SHARP & DOHME | 2013-05-08 | — | — | CN | disclosed |
| US-8324410-B2 | Modified drugs for use in liposomal nanoparticles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2012-12-04 | — | — | US | disclosed |
| CN-1950750-B | Pattern forming material, pattern forming apparatus, and pattern forming method | ASAHI KASEI E MATERIALS CORP | 2012-10-24 | — | — | CN | disclosed |
| WO-2012136492-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2012-10-11 | — | — | WO | disclosed |
| CN-101052918-B | Photosensitive composition, pattern forming material, photosensitive laminate, pattern forming apparatus, and pattern forming method | ASAHI KASEI E MATERIALS CORP | 2012-09-26 | — | — | CN | disclosed |
| US-20120237591-A1 | MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2012-09-20 | — | — | US | disclosed |
| WO-2012117000-A1 | 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2012-09-07 | — | — | WO | disclosed |
| US-8258156-B2 | Compounds and compositions as modulators of GPR119 activity | IRM LLC (BM) | 2012-09-04 | — | — | US | disclosed |
| WO-2012101652-A2 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PVT. LTD (IN) | 2012-08-02 | — | — | WO | disclosed |
| US-20120196844-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | IRM LLC (BM) | 2012-08-02 | — | — | US | disclosed |
| WO-2012097684-A1 | BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2012-07-26 | — | — | WO | disclosed |
| EP-2475666-A2 | GYRASE INHIBITORS | Trius Therapeutics, Inc. (US) | 2012-07-18 | — | — | EP | disclosed |
| WO-2012081736-A1 | CONTINUOUS ARYCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-06-21 | — | — | WO | disclosed |
| EP-2451279-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS | Akebia Therapeutics Inc. (US) | 2012-05-16 | — | — | EP | disclosed |
| WO-2012047966-A2 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | AKEBIA THERAPEUTICS INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012003274-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY | AMGEN INC. (US) | 2012-01-05 | — | — | WO | disclosed |
| EP-2389352-A2 | ARGINASE INHIBITORS AND METHODS OF USE | The Trustees Of The University Of Pennsylvania (US) | 2011-11-30 | — | — | EP | disclosed |
| EP-2385763-A1 | METHODS FOR TREATING VASCULAR LEAK SYNDROME | Akebia Therapeutics Inc. (US) | 2011-11-16 | — | — | EP | disclosed |
| EP-2379552-A1 | SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS | Ortho-McNeil-Janssen Pharmaceuticals, Inc. (US) | 2011-10-26 | — | — | EP | disclosed |
| US-20110253725-A1 | MULTI-PORT BEVERAGE AND FOOD CONTAINERS | KILLIAN WILLIAM | 2011-10-20 | — | — | US | disclosed |
| EP-2375899-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | Array Biopharma, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| US-8040818-B2 | Method for exchange of upkeep-relevant information with a computer-supported, upkeep system | ENDRESS + HAUSER PROCESS SOLUTIONS AG (CH) | 2011-10-18 | — | — | US | disclosed |
| US-8022210-B2 | 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma | PARION SCIENCES, INC. (US) | 2011-09-20 | — | — | US | disclosed |
| US-20110224185-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY | IRM LLC, a Delaware Limited Company (BM) | 2011-09-15 | — | — | US | disclosed |
| US-8008494-B2 | 2-(4-{4-[N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]-butyl}phenoxy)-N-(3-dimethylaminopropyl)acetamide dimethanesulfonate; promoting hydration of mucosal surfaces; Sjogren's disease, esophagitis, pneumonia, asthma, otitis, constipation, chronic diverticulitis, rhinosinusitis | PARION SCIENCES, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-7998916-B2 | Replacement solvents having improved properties and methods of using the same | MAINSTREAM ENGINEERING CORPORATION (US) | 2011-08-16 | — | — | US | disclosed |
| US-7998951-B2 | treating hepatitis C infection; 6-cyclohexyl-2,3-dihydro-5-phenyl-1,4-oxazino[2,3,4-hi]indole-9-carboxylic acid | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-08-16 | — | — | US | disclosed |
| US-20110190323-A1 | CORTISTATIN ANALOGUES AND SYNTHESES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-08-04 | — | — | US | disclosed |
| US-20110165225-A1 | Modified Drugs for Use in Liposomal Nanoparticles | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-07-07 | — | — | US | disclosed |
| EP-2334686-A2 | CORTISTATIN ANALOGUES AND SYNTHESES THEROF | President and Fellows of Harvard College (US) | 2011-06-22 | — | — | EP | disclosed |
| US-7960331-B2 | Replacement solvents having improved properties and methods of using the same | GRZYLL LAWRENCE R | 2011-06-14 | — | — | US | disclosed |
| EP-2329826-A1 | Tetracyclines for the treatment of multiple sclerosis | Paratek Pharmaceuticals, Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| EP-2329828-A1 | Tetracyclines for the treatment of ischaemia | Paratek Pharmaceuticals, Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| CN-102014626-A | Steroidal ligands and their use in gene switch modulation | INTREXON CORP | 2011-04-13 | — | — | CN | disclosed |
| US-20110082280-A1 | Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules | BRACCO IMAGING S.P.A. (IT) | 2011-04-07 | — | — | US | disclosed |
| EP-2301550-A1 | Tetracycline compounds having target therapeutic activities | Paratek Pharmaceuticals, Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| EP-2300463-A1 | HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS | AstraZeneca AB (SE) | 2011-03-30 | — | — | EP | disclosed |
| US-20110064698-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2011-03-17 | — | — | US | disclosed |
| WO-2011032050-A2 | GYRASE INHIBITORS | TRIUS THERAPEUTICS, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011005330-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS | AKEBIA THERAPEUTICS INC. (US) | 2011-01-13 | — | — | WO | disclosed |
| EP-2265116-A2 | STEROIDAL LIGANDS AND THEIR USE IN GENE SWITCH MODULATION | Intrexon Corporation (US) | 2010-12-29 | — | — | EP | disclosed |
| US-7842697-B2 | Soluble amide and ester pyrazinoylguanidine sodium channel blockers | PARION SCIENCES, INC. (US) | 2010-11-30 | — | — | US | disclosed |
| EP-2235019-A1 | IMIDAZO [1,2-B] PYRIDAZINE COMPOUNDS AS MODULATORS OF LIVER X RECEPTORS | Wyeth LLC (US) | 2010-10-06 | — | — | EP | disclosed |
| CN-101854930-A | Novel STAT3 pathway inhibitor and cancer stem cell pathway inhibitor | BOSTON BIOMEDICAL INC | 2010-10-06 | — | — | CN | disclosed |
| EP-2231660-A1 | IMIDAZO [1,2-A] PYRIDINE COMPOUNDS | Wyeth LLC (US) | 2010-09-29 | — | — | EP | disclosed |
| CN-101842098-A | Nitrogen-containing bicyclic chemical entities for the treatment of viral infections | GENELABS TECH INC | 2010-09-22 | — | — | CN | disclosed |
| EP-2227466-A2 | HETEROARYL-SUBSTITUTED PIPERIDINES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010085797-A2 | ARGINASE INHIBITORS AND METHODS OF USE | THE TRUSTEES OF UNIVERSITY OF PENNSYLVANIA (US) | 2010-07-29 | — | — | WO | disclosed |
| WO-2010081172-A1 | METHODS FOR TREATING VASCULAR LEAK SYNDROME | AKEBIA THERAPEUTICS INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010080864-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010070008-A1 | SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS | ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC (US) | 2010-06-24 | — | — | WO | disclosed |
| CN-1751025-B | Diamine derivatives | DAIICHI SEIYAKU CO | 2010-05-12 | — | — | CN | disclosed |
| WO-2010024930-A2 | CORTISTATIN ANALOGUES AND SYNTHESES THEROF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-03-04 | — | — | WO | disclosed |
| US-20090324724-A1 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS | PARION SCIENCES, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| WO-2009147433-A1 | HETEROCYCLIC UREA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS | ASTRAZENECA AB (SE) | 2009-12-10 | — | — | WO | disclosed |
| US-20090286878-A1 | POLYOL DERIVED ANTI-MICROBIAL AGENTS AND COMPOSITIONS | CIBA CORP. | 2009-11-19 | — | — | US | disclosed |
| EP-2117309-A1 | BICYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck & Co., Inc. (US) | 2009-11-18 | — | — | EP | disclosed |
| US-20090238761-A1 | Novel Aryl Piperazine Derivatives With Medical Utility | UNIVERSITA DEGLI STUDI DI SIENA (IT) | 2009-09-24 | — | — | US | disclosed |
| EP-2102199-A1 | ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS | AstraZeneca AB (SE) | 2009-09-23 | — | — | EP | disclosed |
| WO-2009114201-A2 | STEROIDAL LIGANDS AND THEIR USE IN GENE SWITCH MODULATION | INTREXON CORPORATION (US) | 2009-09-17 | — | — | WO | disclosed |
| EP-1796665-A4 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | MERCK & CO INC (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2009086130-A1 | IMIDAZO [1,2-B] PYRIDAZINE COMPOUNDS AS MODULATORS OF LIVER X RECEPTORS | WYETH (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009086123-A1 | IMIDAZO [1,2-A] PYRIDINE COMPOUNDS | WYETH (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009068214-A2 | HETEROARYL-SUBSTITUTED PIPERIDINES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-06-04 | — | — | WO | disclosed |
| EP-2049200-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MethylGene Inc. (CA) | 2009-04-22 | — | — | EP | disclosed |
| EP-2046333-A2 | THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS | SmithKline Beecham Corporation (US) | 2009-04-15 | — | — | EP | disclosed |
| CN-100478785-C | Pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2009-04-15 | — | — | CN | disclosed |
| EP-2044061-A2 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | Kahraman, Mehmet (US) | 2009-04-08 | — | — | EP | disclosed |
| EP-2041102-A2 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | The Procter & Gamble Company (US) | 2009-04-01 | — | — | EP | disclosed |
| EP-2038265-A2 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | The Procter and Gamble Company (US) | 2009-03-25 | — | — | EP | disclosed |
| US-20090076273-A1 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS | PARION SCIENCES, INC. (US) | 2009-03-19 | — | — | US | disclosed |
| EP-1828224-A4 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES | AMBRX INC (US) | 2009-02-25 | — | — | EP | disclosed |
| EP-2024376-A1 | NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE | Merck & Co., Inc. (US) | 2009-02-18 | — | — | EP | disclosed |
| EP-2024349-A2 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | Abbott Laboratories (US) | 2009-02-18 | — | — | EP | disclosed |
| CN-100433254-C | Pattern forming process | FUJI PHOTO FILM CO LTD (JP) | 2008-11-12 | — | — | CN | disclosed |
| EP-1971596-A2 | FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS MINERALOCORTICOID RECEPTOR LIGANDS | Takeda Pharmaceutical Company Limited (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-20080221090-A1 | HCV NS5B Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2008-09-11 | — | — | US | disclosed |
| EP-1951669-A1 | ACYL INDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | Merck & Co., Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| EP-1948652-A1 | GLUCOKINASE ACTIVATORS | Array Biopharma, Inc. (US) | 2008-07-30 | — | — | EP | disclosed |
| US-20080177072-A1 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS | PARION SCIENCES, INC. (US) | 2008-07-24 | — | — | US | disclosed |
| US-20080171879-A1 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS | PARION SCIENCES, INC. (US) | 2008-07-17 | — | — | US | disclosed |
| WO-2008085509-A1 | BICYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| US-7399766-B2 | Soluble amide & ester pyrazinoylguanidine sodium channel blockers | PARION SCIENCES, INC. (US) | 2008-07-15 | — | — | US | disclosed |
| CN-101218546-A | Pattern forming method | FUJIFILM CORP (JP) | 2008-07-09 | — | — | CN | disclosed |
| EP-1934228-A2 | RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | Array Biopharma, Inc. (US) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008073142-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK & CO., INC. (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008068470-A1 | ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS | ASTRAZENECA AB (SE) | 2008-06-12 | — | — | WO | disclosed |
| EP-1924560-A1 | 6-SUBSTITUTED- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2008-05-28 | — | — | EP | disclosed |
| EP-1919898-A1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | Tibotec Pharmaceuticals Ltd. (IE) | 2008-05-14 | — | — | EP | disclosed |
| WO-2008014219-A2 | THIOZOLIDINEDIONE DERIVATIVES AS P13 KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-01-31 | — | — | WO | disclosed |
| WO-2008011560-A2 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | KAHRAMAN MEHMET (US) | 2008-01-24 | — | — | WO | disclosed |
| CN-101103310-A | Material for pattern formation, apparatus for pattern formation, and method for pattern formation | FUJI FILM CORP (JP) | 2008-01-09 | — | — | CN | disclosed |
| WO-2008002570-A2 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2008002569-A2 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007140439-A2 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007139729-A1 | NOVEL SULFONAMIDOMETHYLPHOSPHONATE INHIBITORS OF BETA-LACTAMASE | MERCK & CO., INC. (US) | 2007-12-06 | — | — | WO | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| CN-101052918-A | Photosensitive composition, pattern forming material, photosensitive laminate, pattern forming apparatus, and pattern forming method | FUJIFILM CORP (JP) | 2007-10-10 | — | — | CN | disclosed |
| EP-1838308-A1 | [4-(HETEROARYL)PIPERAZIN-1-YL]-(2,5-SUBSTITUTED -PHENYL)METHANONE DERIVATIVES AS GLYCINE TRANSPORTER 1 (GLYT-1) INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | F. Hoffmann-Roche AG (CH) | 2007-10-03 | — | — | EP | disclosed |
| EP-1838711-A2 | ANTI-TUMOR COMPOUNDS | National Health Research Institutes (TW) | 2007-10-03 | — | — | EP | disclosed |
| CN-100336792-C | Total synthesis method for preparing receme alkannin | UNIV SHANGHAI JIAOTONG (CN) | 2007-09-12 | — | — | CN | disclosed |
| EP-1828224-A2 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES | Ambrx, Inc. (US) | 2007-09-05 | — | — | EP | disclosed |
| CN-101010636-A | Pattern forming material, pattern forming apparatus, and pattern forming method | FUJI FILM CORP (JP) | 2007-08-01 | — | — | CN | disclosed |
| WO-2007077961-A2 | FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS MINERALOCORTICOID RECEPTOR LIGANDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-07-12 | — | — | WO | disclosed |
| CN-1997944-A | Pattern forming method | FUJI FILM CORP (JP) | 2007-07-11 | — | — | CN | disclosed |
| EP-1796665-A2 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | Merck & Co., Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| CN-1977221-A | Pattern forming method, color filter manufacturing method, color filter, and liquid crystal display | FUJI PHOTO FILM CO LTD (JP) | 2007-06-06 | — | — | CN | disclosed |
| WO-2007053345-A1 | GLUCOKINASE ACTIVATORS | ARRAY BIOPHARMA INC. (US) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007047177-A1 | ACYL INDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK & CO., INC. (US) | 2007-04-26 | — | — | WO | disclosed |
| CN-1950750-A | Pattern forming material, pattern forming apparatus, and pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2007-04-18 | — | — | CN | disclosed |
| CN-1950753-A | Pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2007-04-18 | — | — | CN | disclosed |
| CN-1934502-A | Pattern forming method and pattern | FUJI PHOTO FILM CO LTD (JP) | 2007-03-21 | — | — | CN | disclosed |
| WO-2007027855-A2 | RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007028082-A1 | 6-SUBSTITUTED- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
| EP-1756112-A1 | PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | Boehringer Ingelheim International GmbH (DE) | 2007-02-28 | — | — | EP | disclosed |
| CN-1918696-A | Pattern forming process | FUJI PHOTO FILM CO LTD (JP) | 2007-02-21 | — | — | CN | disclosed |
| WO-2007014922-A1 | MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2007-02-08 | — | — | WO | disclosed |
| US-20070021439-A1 | Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers | PARION SCIENCES, INC. | 2007-01-25 | — | — | US | disclosed |
| EP-1713784-A1 | IMIDAZO-PYRIDAZINES, TRIAZOLO-PYRIDAZINES AND RELATED BENZODIAZEPINE RECEPTOR LIGANDS | NEUROGEN CORPORATION (US) | 2006-10-25 | — | — | EP | disclosed |
| EP-1483257-B1 | QUINAZOLINE COMPOUNDS USEFUL IN THERAPY | PFIZER LTD (GB) | 2006-09-13 | — | — | EP | disclosed |
| WO-2006069246-A9 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES | AMBRX INC (US) | 2006-08-31 | — | — | WO | disclosed |
| WO-2006072436-A1 | [4-(HETEROARYL) PIPERAZIN-1-YL]-(2,5-SUBSTITUTED -PHENYL)METHANONE DERIVATIVES AS GLYCINE TRANSPORTER 1 (GLYT-1) INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-07-13 | — | — | WO | disclosed |
| WO-2006074041-A2 | ANTI-TUMOR COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2006-07-13 | — | — | WO | disclosed |
| WO-2006069246-A2 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES | AMBRX, INC. (US) | 2006-06-29 | — | — | WO | disclosed |
| EP-1558252-A4 | SUBSTITUTED FURO 2,3-B| PYRIDINE DERIVATIVES | MERCK & CO INC (US) | 2006-05-17 | — | — | EP | disclosed |
| CN-1255404-C | Process for preparing substituted imidazopyridine compounds | ASTRAZENECA AB (SE) | 2006-05-10 | — | — | CN | disclosed |
| EP-1644357-A1 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2006033891-A2 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | MERCK & CO., INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1385524-A4 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | ABBOTT GMBH & CO KG (DE) | 2006-02-01 | — | — | EP | disclosed |
| EP-1620435-A1 | IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY AND 5-HT sb 3 /sb RECEPTOR ANTAGONISTIC ACTIVITY | PFIZER INC. (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2005111040-A1 | PYRROLOBENZIMIDAZOLONES AND THEIR USE AS ANTIPROLIFERATIVE AGENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| CN-1686994-A | Total synthesis method for preparing receme alkannin | UNIV SHANGHAI JIAOTONG (CN) | 2005-10-26 | — | — | CN | disclosed |
| CN-1673863-A | Pattern forming material, pattern forming apparatus and pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2005-09-28 | — | — | CN | disclosed |
| WO-2005080355-A1 | IMIDAZO-PYRIDAZINES, TRIAZOLO-PYRIDAZINES AND RELATED BENZODIAZEPINE RECEPTOR LIGANDS | NEUROGEN CORPORATION (US) | 2005-09-01 | — | — | WO | disclosed |
| US-6936619-B2 | Cardiovascular disorders; antilipemic agents; sexual disorders | PFIZER, INC. (US) | 2005-08-30 | — | — | US | disclosed |
| CN-1655059-A | Photosensitive transfer sheet, photosensitive laminated article, forming method of image pattern and cloth wire pattern | FUJI PHOTO FILM CO LTD (JP) | 2005-08-17 | — | — | CN | disclosed |
| EP-1558252-A2 | SUBSTITUTED FURO 2,3-B] PYRIDINE DERIVATIVES | Merck & Co., Inc. (US) | 2005-08-03 | — | — | EP | disclosed |
| EP-1556032-A1 | AGENT FOR PREVENTING OR TREATING NEUROPATHY | Takeda Pharmaceutical Company Limited (JP) | 2005-07-27 | — | — | EP | disclosed |
| CN-1641481-A | Light-sensitive transfer sheet, light-sensitive layers, method for forming image pattern and method for distribution pattern | FUJI PHOTO FILM CO LTD (JP) | 2005-07-20 | — | — | CN | disclosed |
| EP-1543005-A1 | IMIDAZOPYRIDINE COMPUNDS AS 5-HT4 RECEPTOR AGONISTS | PFIZER INC. (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1543004-A1 | N-SUBSTITUTED PIPERIDINYL-IMIDAZOPYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS | PFIZER INC. (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1527070-A1 | AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS | Applied Research Systems ARS Holding N.V. (AN) | 2005-05-04 | — | — | EP | disclosed |
| CN-1612048-A | Method for making printed circuit board | FUJI PHOTO FILM CO LTD (JP) | 2005-05-04 | — | — | CN | disclosed |
| WO-2005007647-A9 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2005-04-07 | — | — | WO | disclosed |
| CN-1580953-A | Light-sensitive transfer sheet, light-sensitive layers, picture pattern forming method and layout pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2005-02-16 | — | — | CN | disclosed |
| CN-1573545-A | Light-sensitive sheet, light-sensitive layers, image pattern forming method, and wiring pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2005-02-02 | — | — | CN | disclosed |
| WO-2005007647-A1 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-1483257-A1 | QUINAZOLINE COMPOUNDS USEFUL IN THERAPY | Pfizer Limited (GB) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004094418-A1 | IMIDAZOPYRIDINE COMPOUNDS HAVING 5-HT4 RECEPTOR AGONISTIC ACTIVITY AND 5-HT3 RECEPTOR ANTAGONISTIC ACTIVITY | PFIZER INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| EP-1011670-A4 | METHOD FOR TREATMENT OF NON-RHEUMATOID ATHRITIS | LILLY CO ELI (US) | 2004-10-27 | — | — | EP | disclosed |
| EP-1448196-A1 | BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | F. Hoffmann-La Roche AG (CH) | 2004-08-25 | — | — | EP | disclosed |
| EP-1440071-A1 | IMIDAZOPYRIDINE COMPOUNDS AS 5-HT 4? RECEPTOR MODULATORS | Pfizer Japan Inc. (JP) | 2004-07-28 | — | — | EP | disclosed |
| WO-2004039365-A1 | AGENT FOR PREVENTING OR TREATING NEUROPATHY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-05-13 | — | — | WO | disclosed |
| WO-2004026869-A1 | IMIDAZOPYRIDINE COMPUNDS AS 5-HT4 RECEPTOR AGONISTS | PFIZER JAPAN INC. (JP) | 2004-04-01 | — | — | WO | disclosed |
| WO-2004026868-A1 | N-SUBSTITUTED PIPERIDINYL-IMIDAZOPYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS | PFIZER JAPAN INC. (JP) | 2004-04-01 | — | — | WO | disclosed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | disclosed |
| EP-1392291-A2 | TRIPEPTIDYL PEPTIDASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-03-03 | — | — | EP | disclosed |
| EP-1212327-B8 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | ABBOTT GMBH & CO KG (DE) | 2004-02-25 | — | — | EP | disclosed |
| EP-1389206-A2 | INHIBITORS OF C-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES | Vertex Pharmaceuticals Incorporated (US) | 2004-02-18 | — | — | EP | disclosed |
| WO-2004012671-A2 | SUBSTITUTED FURO [2,3-B] PYRIDINE DERIVATIVES | MERCK & CO., INC. (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20040029859-A1 | Compounds useful in therapy | PFIZER INC. | 2004-02-12 | — | — | US | disclosed |
| EP-1385524-A1 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | Abbott GmbH & Co. KG (DE) | 2004-02-04 | — | — | EP | disclosed |
| WO-2003106455-A1 | AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2003-12-24 | — | — | WO | disclosed |
| EP-1370536-A1 | METALLOPROTEINASE INHIBITORS | AstraZeneca AB (SE) | 2003-12-17 | — | — | EP | disclosed |
| EP-1370534-A1 | METALLOPROTEINASE INHIBITORS | AstraZeneca AB (SE) | 2003-12-17 | — | — | EP | disclosed |
| WO-2003093250-A2 | POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR | PHARMACIA & UPJOHN COMPANY (US) | 2003-11-13 | — | — | WO | disclosed |
| CN-1452621-A | Process for preparing substd. imidazopyridine compound | ASTRAZENECA AB (SE) | 2003-10-29 | — | — | CN | disclosed |
| EP-1345954-A2 | METHODS UTILIZING ARYL THIOIMINES IN SYNTHESIS OF ERYTHROMYCIN DERIVATIVES | Abbott Laboratories (US) | 2003-09-24 | — | — | EP | disclosed |
| WO-2003076427-A1 | QUINAZOLINE COMPOUNDS USEFUL IN THERAPY | PFIZER LIMITED (GB) | 2003-09-18 | — | — | WO | disclosed |
| US-6602647-B2 | Photo acid generator with high transparency and excellent heat stability in a photoresist for lithography using far ultraviolet light, especially light of ArF excimer consists of a cyclic sulfonium compound with 2-oxo group | NEC CORPORATION (JP) | 2003-08-05 | — | — | US | disclosed |
| WO-2002036116-A9 | TRIPEPTIDYL PEPTIDASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2003-05-30 | — | — | WO | disclosed |
| WO-2003043634-A1 | BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-05-30 | — | — | WO | disclosed |
| EP-1307453-A2 | DIHYDRONAPHTHYRIDINE- AND DIHYDROPYRROLOPYRIDINE-DERIVATED COMPOUNDS AS POTASSIUM CHANNEL OPENERS | ABBOTT LABORATORIES (US) | 2003-05-07 | — | — | EP | disclosed |
| WO-2003035649-A1 | IMIDAZOPYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS | PFIZER JAPAN INC. (JP) | 2003-05-01 | — | — | WO | disclosed |
| EP-1286988-A2 | 1-(H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL DERIVATIVES | Basilea Pharmaceutica AG (CH) | 2003-03-05 | — | — | EP | disclosed |
| EP-1091738-A4 | BICYCLIC sPLA 2 INHIBITORS | LILLY CO ELI (US) | 2003-03-05 | — | — | EP | disclosed |
| WO-2003016311-A1 | TRICYCLIC PYRIDIN-2-ONE ANALOGUES AS LIGANDS FOR GABA-A RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2003-02-27 | — | — | WO | disclosed |
| EP-1259923-A2 | ANTI-INFECTIVE AGENTS USEFUL AGAINST MULITIDRUG-RESISTANT STRAINS OF BACTERIA | ABBOTT LABORATORIES (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1259260-A1 | COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES | ELI LILLY AND COMPANY (US) | 2002-11-27 | — | — | EP | disclosed |
| WO-2002083667-A2 | INHIBITORS OF C-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002080926-A1 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | ABBOTT GMBH & CO. KG (DE) | 2002-10-17 | — | — | WO | disclosed |
| WO-2002074750-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002074748-A1 | METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-26 | — | — | WO | disclosed |
| WO-2001016139-A9 | ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARM INC (US) | 2002-09-19 | — | — | WO | disclosed |
| WO-2002050093-A2 | METHODS UTILIZING ARYL THIOIMINES IN SYNTHESIS OF ERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 2002-06-27 | — | — | WO | disclosed |
| EP-1214041-A2 | COMBINATION THERAPY FOR THE TREATMENT OF SEPSIS | ELI LILLY AND COMPANY (US) | 2002-06-19 | — | — | EP | disclosed |
| EP-1212327-A2 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1206474-A1 | SULFONYLPHENYLPYRAZOLE COMPOUNDS USEFUL AS COX-2 INHIBITORS | ABBOTT LABORATORIES (US) | 2002-05-22 | — | — | EP | disclosed |
| US-20020058665-A1 | Imidazole derivatives and their use as farnesyl protein transferase inhibitors | ASTRAZENECA UK LIMITED | 2002-05-16 | — | — | US | disclosed |
| WO-2002036116-A2 | TRIPEPTIDYL PEPTIDASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-05-10 | — | — | WO | disclosed |
| US-20020052376-A1 | Imidazole derivatives and their use as farnesyl protein transferase inhibitors | ASTRAZENECA UK LIMITED | 2002-05-02 | — | — | US | disclosed |
| US-20020045122-A1 | Sulfonium salt compound and resist composition and pattern forming method using the same | NEC CORPORATION | 2002-04-18 | — | — | US | disclosed |
| WO-2002010164-A2 | DIHYDRONAPHTHYRIDINE- AND DIHYDROPYRROLOPYRIDINE-DERIVATED COMPOUNDS AS POTASSIUM CHANNEL OPENERS | ABBOTT LABORATORIES (US) | 2002-02-07 | — | — | WO | disclosed |
| US-6342765-B1 | COMPOUNDS THAT INHIBIT FARNESYLATION OF MUTANT RAS GENE PRODUCTS; TREATING DISEASES, ESPECIALLY CANCER, WHICH ARE MEDIATED THROUGH FARNESYLATION OF RAS | ASTRAZENECA UK LIMITED (GB) | 2002-01-29 | — | — | US | disclosed |
| WO-2001096335-A1 | IMIDAZO[1,2-A]PYRIDINE ETHER COMPOUNDS AS ION CHANNEL MODULATORS | CARDIOME PHARMA CORP. (CA) | 2001-12-20 | — | — | WO | disclosed |
| EP-1161438-A1 | 6-O-SUBSTITUTED MACROLIDES HAVING ANTIBACTERIAL ACTIVITY | ABBOTT LABORATORIES (US) | 2001-12-12 | — | — | EP | disclosed |
| CN-1075499-C | Quinolone-and naphthyridonecarboxylic acid derivatives | BAYER AG (DE) | 2001-11-28 | — | — | CN | disclosed |
| WO-2001079196-A2 | 1-(H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL DERIVATIVES | BASILEA PHARMACEUTICA AG (CH) | 2001-10-25 | — | — | WO | disclosed |
| CN-1072657-C | 1,2, 3-thiadiazole derivative and salt thereof, agrohorticultural virus control agent, and method for using same | NIHON NOHYAKU CO LTD (JP) | 2001-10-10 | — | — | CN | disclosed |
| EP-1025088-B1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | ASTRAZENECA AB (SE) | 2001-09-05 | — | — | EP | disclosed |
| WO-2001063539-A2 | ANTI-INFECTIVE AGENTS USEFUL AGAINST MULTIDRUG-RESISTANT STRAINS OF BACTERIA | ABBOTT LABORATORIES (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2001049323-A1 | COMBINATION THERAPY FOR THE TREATMENT OF INFLAMMATORY AND RESPIRATORY DISEASES | ELI LILLY AND COMPANY (US) | 2001-07-12 | — | — | WO | disclosed |
| EP-1100786-A1 | ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | Samjin Pharmaceutical Co., Ltd. (KR) | 2001-05-23 | — | — | EP | disclosed |
| EP-1091738-A1 | BICYCLIC sPLA 2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2001019829-A2 | PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-22 | — | — | WO | disclosed |
| WO-2001016138-A1 | SULFONYLPHENYLPYRAZOLE COMPOUNDS USEFUL AS COX-2 INHIBITORS | ABBOTT LABORATORIES (US) | 2001-03-08 | — | — | WO | disclosed |
| EP-1066290-A1 | PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2001-01-10 | — | — | EP | disclosed |
| EP-1056771-A1 | STREPTOGRAMIN DERIVATIVES, PREPARATION METHOD AND COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000061564-A1 | ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | SAMJIN PHARMACEUTICAL CO., LTD. (KR) | 2000-10-19 | — | — | WO | disclosed |
| WO-2000061563-A1 | ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | SAMJIN PHARMACEUTICAL CO., LTD. (KR) | 2000-10-19 | — | — | WO | disclosed |
| EP-1037630-A2 | METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 2000-09-27 | — | — | EP | disclosed |
| WO-2000055168-A1 | 6-O-SUBSTITUTED MACROLIDES HAVING ANTIBACTERIAL ACTIVITY | ABBOTT LABORATORIES (US) | 2000-09-21 | — | — | WO | disclosed |
| EP-1036092-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 2000-09-20 | — | — | EP | disclosed |
| EP-1027360-A2 | 3-DESCLADINOSE 6-O-SUBSTITUDED ERYTHROMYCIN DERIVATIVES | Abbott Laboratories (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1027362-A1 | 2-HALO-6-O-SUBSTITUTED KETOLIDE DERIVATIVES | Abbott Laboratories (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1025088-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | AstraZeneca UK Limited (GB) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000037022-A2 | COMBINATION THERAPY FOR THE TREATMENT OF SEPSIS | ELI LILLY AND COMPANY (US) | 2000-06-29 | — | — | WO | disclosed |
| EP-1011670-A1 | METHOD FOR TREATMENT OF NON-RHEUMATOID ATHRITIS | ELI LILLY AND COMPANY (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-1007056-A1 | METHOD FOR THE TREATMENT OF CYSTIC FIBROSIS | ELI LILLY AND COMPANY (US) | 2000-06-14 | — | — | EP | disclosed |
| EP-1007530-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 2000-06-14 | — | — | EP | disclosed |
| EP-0977566-A1 | METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 2000-02-09 | — | — | EP | disclosed |
| WO-2000000201-A1 | BICYCLIC sPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |
| CN-1232458-A | 1,2,3-thiadiazole derivs. and salts thereof, disease agent for agricultural and horticultural use and method for use thereof | NIHON NOHYAKU CO LTD (JP) | 1999-10-20 | — | — | CN | disclosed |
| WO-1999051605-A1 | PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR | SHIONOGI & CO., LTD. (JP) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999028343-A9 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN INC (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999043699-A1 | STREPTOGRAMIN DERIVATIVES, PREPARATION METHOD AND COMPOSITIONS CONTAINING SAME | AVENTIS PHARMA S.A. (FR) | 1999-09-02 | — | — | WO | disclosed |
| EP-0929563-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | Abbott Laboratories (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1999028876-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| WO-1999028343-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| EP-0920425-A1 | SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL-AMINO)PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0918783-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1999-06-02 | — | — | EP | disclosed |
| WO-1999024033-A1 | METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 1999-05-20 | — | — | WO | disclosed |
| WO-1999024026-A2 | METHOD FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH APOPTOSIS USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 1999-05-20 | — | — | WO | disclosed |
| WO-1999021871-A1 | 2-HALO-6-O-SUBSTITUTED KETOLIDE DERIVATIVES | ABBOTT LABORATORIES (US) | 1999-05-06 | — | — | WO | disclosed |
| WO-1999020611-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | ZENECA LIMITED (GB) | 1999-04-29 | — | — | WO | disclosed |
| CN-1043142-C | Quinolone-and naphthyridonecarboxylic acid derivatives, their preparation and use | BAYER AG (DE) | 1999-04-28 | — | — | CN | disclosed |
| WO-1999016453-A1 | METHOD FOR THE TREATMENT OF CYSTIC FIBROSIS | ELI LILLY AND COMPANY (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1999011651-A2 | 3-DESCLADINOSE 6-O-SUBSTITUDED ERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1999-03-11 | — | — | WO | disclosed |
| WO-1999009978-A1 | METHOD FOR TREATMENT OF NON-RHEUMATOID ATHRITIS | ELI LILLY AND COMPANY (US) | 1999-03-04 | — | — | WO | disclosed |
| EP-0863755-A4 | ANTITHROMBOTIC DIAMINES | LILLY CO ELI (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0772596-A4 | INDOLIZINE sPLA2 INHIBITORS | LILLY CO ELI (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1999000669-A1 | NUCLEOBASE HETEROCYCLIC COMBINATORIALIZATION | ISIS PHARMACEUTICALS, INC. (US) | 1999-01-07 | — | — | WO | disclosed |
| CN-1040979-C | Antipsychotic method | NOVO NORDISK AS (DK) | 1998-12-02 | — | — | CN | disclosed |
| EP-0874843-A1 | NOVEL SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPANES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1998047508-A1 | METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS | SHIONOGI & CO., LTD. (JP) | 1998-10-29 | — | — | WO | disclosed |
| EP-0863755-A1 | ANTITHROMBOTIC DIAMINES | ELI LILLY AND COMPANY (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1998009978-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | ABBOTT LABORATORIES (US) | 1998-03-12 | — | — | WO | disclosed |
| EP-0808309-A1 | IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS S-ADENOSYLMETHIONINE DECARBOXYLASE (=SAMDC) INHIBITORS | Novartis AG (CH) | 1997-11-26 | — | — | EP | disclosed |
| WO-1997042204-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | disclosed |
| WO-1997025033-A1 | ANTITHROMBOTIC DIAMINES | ELI LILLY AND COMPANY (US) | 1997-07-17 | — | — | WO | disclosed |
| WO-1997022604-A1 | NOVEL SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-06-26 | — | — | WO | disclosed |
| EP-0755527-A4 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES INC (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1997019074-A1 | SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL-AMINO)PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-05-29 | — | — | WO | disclosed |
| EP-0772596-A1 | INDOLIZINE sPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| EP-0755527-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1996022979-A1 | IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS S-ADENOSYLMETHIONINE DECARBOXYLASE (=SAMDC) INHIBITORS | NOVARTIS AG (CH) | 1996-08-01 | — | — | WO | disclosed |
| WO-1996003383-A1 | INDOLIZINE sPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 1996-02-08 | — | — | WO | disclosed |
| US-5427779-A | Irradiating a solid polymer and a compound such as substitued indoles, benzofurans, angelicins, coumarins etc; heterogeneous immunoassays; fixing; surface treatment | NUNC A/S (DK) | 1995-06-27 | — | — | US | disclosed |
| EP-0602069-A4 | RETROVIRAL PROTEASE INHIBITORS. | SMITHKLINE BEECHAM CORP (US) | 1995-05-03 | — | — | EP | disclosed |
| CN-1095710-A | Enzyme Inhibitors | WELLCOME FOUND (GB) | 1994-11-30 | — | — | CN | disclosed |
| EP-0533837-A4 | INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES | SMITHKLINE BEECHAM CORP (US) | 1994-11-17 | — | — | EP | disclosed |
| CN-1026048-C | Use of solsonylurea compounds as herbicide | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1994-10-05 | — | — | CN | disclosed |
| EP-0602069-A1 | RETROVIRAL PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-06-22 | — | — | EP | disclosed |
| EP-0390841-B1 | A METHOD FOR MODIFYING THE SURFACE OF A POLYMER | GLUETECH APS (DK) | 1993-11-24 | — | — | EP | disclosed |
| EP-0533837-A1 | INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-03-31 | — | — | EP | disclosed |
| CN-1018643-B | Process for producing sulfonylurea compound | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1992-10-14 | — | — | CN | disclosed |
| CN-1059073-A | Solsonylurea compounds is as the purposes of weed killer herbicide | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1992-03-04 | — | — | CN | disclosed |
| WO-1991019497-A1 | INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-26 | — | — | WO | disclosed |
| US-5041653-A | Antitumor agents | SRI INTERNATIONAL (US) | 1991-08-20 | — | — | US | disclosed |
| US-5032617-A | Antitumor agents | SRI INTERNATIONAL (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0390841-A1 | A METHOD FOR MODIFYING THE SURFACE OF A POLYMER. | GLUETECH APS (DK) | 1990-10-10 | — | — | EP | disclosed |
| WO-1989005329-A1 | A METHOD FOR MODIFYING THE SURFACE OF A POLYMER | GLUETECH APS (DK) | 1989-06-15 | — | — | WO | disclosed |
| EP-0319957-A2 | A method for modifying the surface of a polymer | GLUETECH APS (DK) | 1989-06-14 | — | — | EP | disclosed |
| EP-0138403-B1 | PROCESS FOR PREPARING PHOSPHINIC ACID INTERMEDIATES | E.R. Squibb & Sons, Inc. (US) | 1989-03-15 | — | — | EP | disclosed |
| CN-87102123-A | Sulfonylurea compounds, their preparation and their use as herbicides | — | 1987-10-21 | — | — | CN | disclosed |
| CN-87100354-A | Derivatives of 7- (azabicycloalkyl) -quinolone-and 7- (azabicycloalkyl) -naphthyridonecarboxylic acids | — | 1987-09-02 | — | — | CN | disclosed |
| EP-0230274-A2 | Derivatives of 7-(azabicycloalkyl)-quinoloncarboxylic acid and -naphthyridoncarboxylic acid | BAYER AG (DE) | 1987-07-29 | — | — | EP | disclosed |
| US-4623432-A | COBALT, MANGANESE AND BROMIDE IONS; FRACTIONAL DISTILLATION | AMOCO CORPORATION (US) | 1986-11-18 | — | — | US | disclosed |
| EP-0190900-A2 | Cephalosporin compounds, their production, and pharmaceutical compositions containing them | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-08-13 | — | — | EP | disclosed |
| US-4602092-A | Method for making phosphinic acid intermediates | E. R. SQUIBB & SONS, INC. (US) | 1986-07-22 | — | — | US | disclosed |
| EP-0061197-B1 | ALPHA CHAIN DIENIC PROSTANOIC ACID DERIVATIVES | G.D. Searle & Co. (US) | 1986-05-21 | — | — | EP | disclosed |
| EP-0138403-A2 | Process for preparing phosphinic acid intermediates | E.R. Squibb & Sons, Inc. (US) | 1985-04-24 | — | — | EP | disclosed |
| EP-0114632-A1 | 5-(4-Vinyl- or 4-ethynylbenzoyl)-1,2-dihydro-3H-pyrrolo-(1,2-A)-pyrrole-1-carboxylic acids and derivatives thereof | SYNTEX (U.S.A.) INC. (US) | 1984-08-01 | — | — | EP | disclosed |
| EP-0061197-A1 | Alpha chain dienic prostanoic acid derivatives | G.D. Searle & Co. (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4312994-A | α Chain dienic prostanoic acid derivatives | G. D. SEARLE & CO. (US) | 1982-01-26 | — | — | US | disclosed |
| US-3992208-A | Photo-sensitive etchant and method for forming metal image using same | FUJI PHOTO FILM CO., LTD. (JA) | 1976-11-16 | — | — | US | disclosed |
| US-3981920-A | Method for preparing cyclopentenone derivatives | FIRMENICH S.A. (CH) | 1976-09-21 | — | — | US | disclosed |
| US-3960559-A | Method of making a semiconductor device utilizing a light-sensitive etching agent | FUJI PHOTO FILM CO., LTD. (JA) | 1976-06-01 | — | — | US | disclosed |
| US-3960559-A | Method of making a semiconductor device utilizing a light-sensitive etching agent | FUJI PHOTO FILM CO., LTD. (JA) | 1976-06-01 | — | — | US | disclosed |